Pharmaceutical marketing for rare diseases: Regulating drug company promotion in an era of unprecedented advertisement Journal Article
| Authors: | Mailankody, S.; Prasad, V. |
| Article Title: | Pharmaceutical marketing for rare diseases: Regulating drug company promotion in an era of unprecedented advertisement |
| Keywords: | myeloproliferative disorders; genetics; janus kinase 2; drug approval; united states; psychology; food and drug administration; health service; prescription; pyrazole derivative; pyrazoles; public health; diagnostic error; short survey; diagnostic test; awareness; patient attitude; drug use; patient acceptance of health care; myeloproliferative neoplasm; marketing; polycythemia vera; rare disease; standards; drug prescriptions; drug industry; rare diseases; jak2 protein, human; drug marketing; procedures; advertising as topic; art; advertising; medicine in art; ruxolitinib; humans; human; priority journal; television; legislation and jurisprudence; direct-to-consumer advertizing; direct-to-consumer advertising; medical overuse |
| Journal Title: | JAMA - Journal of the American Medical Association |
| Volume: | 317 |
| Issue: | 24 |
| ISSN: | 0098-7484 |
| Publisher: | American Medical Association |
| Date Published: | 2017-06-27 |
| Start Page: | 2479 |
| End Page: | 2480 |
| Language: | English |
| DOI: | 10.1001/jama.2017.5784 |
| PUBMED: | 28520871 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Short Survey -- Export Date: 2 August 2017 -- Source: Scopus |
